TNFAIP2 and acute myeloid leukemia: As shown in Fig. 5a, TNFAIP2 was differentially expressed among different FAB subtypes of AML with the lowest expression in FAB-M3 and highest in FAB-M4/M5 patients (Fig. 5a, Supplementary Table S1).